Chemical nature and the problem of resistance
In pharmacological classification, ethambutol belongs to the group of synthetic antibacterial agents. From a chemical standpoint, the drug molecule is an ethylenediamine derivative. When studying the structural formulas of antituberculosis drugs, it is often considered alongside the thioamide group, which includes ethionamide and prothionamide. However, it is precisely its status as an ethylenediamine derivative that endows ethambutol with its unique properties.
The main clinical advantage of ethambutol is its ability to overcome drug resistance of the pathogen. A huge problem in therapy is cross-resistance, when bacteria stop responding to related drugs. Due to a completely unique mechanism of action, ethambutol retains high therapeutic activity against those mycobacterial strains that have already developed resistance to classical drugs such as streptomycin and isoniazid.
Mechanism of action: hitting the cell wall
The effect of ethambutol on mycobacteria is characterized by high selectivity. The drug does not simply destroy the cell, but disrupts the process of its natural construction. This process can be divided into several key stages:
- Target search: upon penetrating the focus of infection, the ethambutol molecule finds its main target — a specific bacterial enzyme, arabinosyltransferase.
- Process blockage: by binding to the enzyme, the drug severely interferes with the biochemical reactions of arabinogalactan synthesis.
- Effect localization: arabinogalactan is a vital building material. Due to its deficiency, the proper construction of the mycobacterial cell wall is disrupted.
As a result of this pharmacological intervention, the bacterium loses its rigid outer shell, making its further reproduction and survival impossible.
Pharmacokinetics: from administration to elimination
Ethambutol has a favorable pharmacokinetic profile that ensures its high efficacy in systemic treatment. The drug's journey in the patient's body is as follows:
- Absorption: the drug is intended for oral administration (by mouth). After entering the gastrointestinal tract (GIT), it demonstrates a very high degree of absorption into the systemic circulation.
- Distribution: ethambutol molecules are characterized by wide distribution. They are able to penetrate most tissues and biological fluids of the body. Of particular importance for clinical practice is the fact that the drug successfully crosses the blood-brain barrier (BBB).
- Elimination: after fulfilling its pharmacological task, the drug is subject to elimination. The main route of elimination of ethambutol from the body is via the kidneys.
Clinical use and toxicity
In clinical practice, ethambutol is prescribed strictly orally. The most important rule of modern pharmacotherapy is the prohibition of monotherapy. Ethambutol is used only as part of combination therapy. Most often, it is prescribed in combination with such potent drugs as rifampicin or isoniazid.
Despite its high efficacy, the use of ethambutol is strictly limited by its adverse effects. The key toxic effect of the drug that every physician must remember is retrobulbar neuritis. This specific damage to the optic nerve has clear clinical manifestations:
- Progressive decrease in visual acuity in the patient.
- Impaired color vision. Primarily, sensitivity to the red-green part of the spectrum is affected (the patient ceases to adequately distinguish red and green colors).
Briefly: answers to topical questions
To which line of antituberculosis drugs (first-line or second-line) does ethambutol belong?
- Ethambutol (Ethambutolum) is a first-line antituberculosis drug (the main drug of choice for the treatment of tuberculosis caused by susceptible mycobacteria).
What adverse effects does ethambutol cause?
- Retrobulbar neuritis is a key toxic effect manifested by a decrease in visual acuity, the appearance of scotomas, constriction of visual fields, pain on eye movement, as well as impaired color vision (loss of sensitivity to the red-green part of the spectrum).
What are the absolute contraindications to prescribing ethambutol?
- Eye diseases (morbi oculorum) — pathologies of the organs of vision accompanied by decreased visual acuity are a direct contraindication to prescribing ethambutol according to the instructions.
Is dose adjustment of ethambutol required in renal failure?
- Dose adjustment (correctio dosas) — required, the drug is included in the group of antituberculosis agents that require a change in dosage or application interval.
To remember the adverse effect of ethambutol, use the traffic light association: ETHAMBUTOL turns off the RED and GREEN lights (loss of sensitivity to the red-green spectrum due to retrobulbar neuritis).
Class and exam questions
Why does ethambutol retain efficacy against strains resistant to isoniazid and streptomycin?
The secret lies in the absence of cross-resistance. Ethambutol has a unique mechanism of action — it selectively blocks the enzyme arabinosyltransferase, whereas isoniazid and streptomycin act on completely different targets.
What are the characteristics of ethambutol distribution in the body after oral administration?
Following high absorption from the gastrointestinal tract, the drug demonstrates a very wide distribution. It penetrates most tissues and fluids, and is also able to cross the blood-brain barrier (BBB).
Is it permissible to use ethambutol as the sole drug for treatment?
Categorically no. According to the rules of use, ethambutol is prescribed exclusively as part of combination therapy (e.g., along with rifampicin or isoniazid).
What specific adverse effect requires visual monitoring?
The main toxic effect of ethambutol is retrobulbar neuritis. It manifests as a decrease in visual acuity and characteristic color vision impairment (loss of sensitivity to the red-green part of the spectrum).
What else to study on this topic
- Detailed analysis of the chemical structure: differences between ethylenediamine derivatives and thioamides (ethionamide and prothionamide).
- Biochemical role of the enzyme arabinosyltransferase in the synthesis of cell wall arabinogalactan.
- Pharmacokinetics of antituberculosis drugs: mechanisms of crossing the blood-brain barrier (BBB).
- Principles of designing combination therapy: synergy of ethambutol with rifampicin and isoniazid.
- Pathogenesis and clinical presentation of retrobulbar neuritis during prolonged ethambutol intake.
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Ethambutol" and 5,304 more pages of the subject
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Antibacterial Chemotherapeutic Agents"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.